Notice of Proposed Modifications of LCs for Phase 1 and 2 Licensees
18 December 2023 | HCSA & Licensing | MOH Cir 89/2023
Summary
1. Proposed Notice - Modifications to Phase 1 & 2 LCs
MOH proposes amendments to Licensing Conditions for Phase 1 and 2 HCSA licensees. Amendments reflect operational experience and emerging regulatory needs. Stakeholder feedback solicited during consultation period.
2. Proposed Amendment Areas
- Technology Integration: Updated requirements for EHR/practice management systems
- Infection Control: Enhanced protocols reflecting post-pandemic best practices
- Medication Management: Stricter controls on controlled and high-risk medications
- Patient Safety: New incident reporting thresholds and escalation procedures
- Professional Development: Expanded CPD requirements
- Facility Standards: Updated infrastructure and equipment standards
- Data Protection: Strengthened confidentiality and security requirements
3. Consultation Process
- Timeline: Consultation period of [specified duration]
- Feedback Channel: Written submissions via MOH designated portal
- Stakeholder Input: Input from licensees, professional bodies, patient groups welcomed
- Consideration Framework: Evidence-based assessment of feedback
4. Next Steps & Timeline
- Feedback deadline: [Date]
- MOH analysis: [Period]
- Finalized amendments: [Date]
- Implementation period: [Duration] from publication
5. Interim Compliance
Current LCs remain in effect during consultation. Licensees should anticipate changes and prepare for compliance with finalized amendments.
Action Items: Review proposed amendments; prepare feedback if applicable; assess current compliance gaps; plan implementation timelines; monitor for finalized versions.
Copy for WhatsApp / Telegram
𝟭. 𝗣𝗿𝗼𝗽𝗼𝘀𝗲𝗱 𝗡𝗼𝘁𝗶𝗰𝗲 - 𝗠𝗼𝗱𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗣𝗵𝗮𝘀𝗲 𝟭 & 𝟮 𝗟𝗖𝘀
MOH proposes amendments to Licensing Conditions for Phase 1 and 2 HCSA licensees. Amendments reflect operational experience and emerging regulatory needs. Stakeholder feedback solicited during consultation period.
𝟮. 𝗣𝗿𝗼𝗽𝗼𝘀𝗲𝗱 𝗔𝗺𝗲𝗻𝗱𝗺𝗲𝗻𝘁 𝗔𝗿𝗲𝗮𝘀
• Technology Integration: Updated requirements for EHR/practice management systems • Infection Control: Enhanced protocols reflecting post-pandemic best practices • Medication Management: Stricter controls on controlled and high-risk medications • Patient Safety: New incident reporting thresholds and escalation procedures • Professional Development: Expanded CPD requirements • Facility Standards: Updated infrastructure and equipment standards • Data Protection:...
𝟯. 𝗖𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗰𝗲𝘀𝘀
• Timeline: Consultation period of [specified duration] • Feedback Channel: Written submissions via MOH designated portal • Stakeholder Input: Input from licensees, professional bodies, patient groups welcomed • Consideration Framework: Evidence-based assessment of feedback
𝟰. 𝗡𝗲𝘅𝘁 𝗦𝘁𝗲𝗽𝘀 & 𝗧𝗶𝗺𝗲𝗹𝗶𝗻𝗲
• Feedback deadline: [Date] • MOH analysis: [Period] • Finalized amendments: [Date] • Implementation period: [Duration] from publication
Documents
Circular
Annexes
- MOH Cir 89_2023 Annex A.1.pdf
- MOH Cir 89_2023 Annex A.2.pdf
- MOH Cir 89_2023 Annex A.3.pdf
- MOH Cir 89_2023 Annex A.4.pdf
- MOH Cir 89_2023 Annex A.5.pdf